Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells

REFERENCES

• Lehtio L, Chi NW, Krauss S. 2013. Tankyrases as drug targets. FEBS J 280:3576–3593. http://dx.doi.org/10.1111/febs.12320.
   PubMed Web of Science ®Google Scholar
• Riffell JL, Lord CJ, Ashworth A. 2012. Tankyrase-targeted therapeutics: expanding opportunities in the PARP family. Nat Rev Drug Discov 11:923–936. http://dx.doi.org/10.1038/nrd3868.
   PubMed Web of Science ®Google Scholar
• Cook BD, Dynek JN, Chang W, Shostak G, Smith S. 2002. Role for the related poly(ADP-ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol Cell Biol 22:332–342. http://dx.doi.org/10.1128/MCB.22.1.332-342.2002.
   PubMed Web of Science ®Google Scholar
• Smith S, Giriat I, Schmitt A, de Lange T. 1998. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282:1484–1487. http://dx.doi.org/10.1126/science.282.5393.1484.
   PubMed Web of Science ®Google Scholar
• Chiang YJ, Hsiao SJ, Yver D, Cushman SW, Tessarollo L, Smith S, Hodes RJ. 2008. Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. PLoS One 3:e2639. http://dx.doi.org/10.1371/journal.pone.0002639.
   PubMed Web of Science ®Google Scholar
• Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, Hild M, Shi X, Wilson CJ, Mickanin C, Myer V, Fazal A, Tomlinson R, Serluca F, Shao W, Cheng H, Shultz M, Rau C, Schirle M, Schlegl J, Ghidelli S, Fawell S, Lu C, Curtis D, Kirschner MW, Lengauer C, Finan PM, Tallarico JA, Bouwmeester T, Porter JA, Bauer A, Cong F. 2009. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614–620. http://dx.doi.org/10.1038/nature08356.
   PubMed Web of Science ®Google Scholar
• Dodge ME, Lum L. 2011. Drugging the cancer stem cell compartment: lessons learned from the hedgehog and Wnt signal transduction pathways. Annu Rev Pharmacol Toxicol 51:289–310. http://dx.doi.org/10.1146/annurev-pharmtox-010510-100558.
   PubMed Web of Science ®Google Scholar
• Chang W, Dynek JN, Smith S. 2005. NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis. Biochem J 391:177–184. http://dx.doi.org/10.1042/BJ20050885.
   PubMed Web of Science ®Google Scholar
• Cho-Park PF, Steller H. 2013. Proteasome regulation by ADP-ribosylation. Cell 153:614–627. http://dx.doi.org/10.1016/j.cell.2013.03.040.
   PubMedGoogle Scholar
• Guettler S, LaRose J, Petsalaki E, Gish G, Scotter A, Pawson T, Rottapel R, Sicheri F. 2011. Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease. Cell 147:1340–1354. http://dx.doi.org/10.1016/j.cell.2011.10.046.
   PubMed Web of Science ®Google Scholar
• Ozaki Y, Matsui H, Asou H, Nagamachi A, Aki D, Honda H, Yasunaga S, Takihara Y, Yamamoto T, Izumi S, Ohsugi M, Inaba T. 2012. Poly-ADP ribosylation of Miki by tankyrase-1 promotes centrosome maturation. Mol Cell 47:694–706. http://dx.doi.org/10.1016/j.molcel.2012.06.033.
   PubMedGoogle Scholar
• Hayashi MT, Cesare AJ, Fitzpatrick JA, Lazzerini-Denchi E, Karlseder J. 2012. A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest. Nat Struct Mol Biol 19:387–394. http://dx.doi.org/10.1038/nsmb.2245.
   PubMedGoogle Scholar
• Sarek G, Vannier JB, Panier S, Petrini JH, Boulton SJ. 2015. TRF2 recruits RTEL1 to telomeres in S phase to promote T-loop unwinding. Mol Cell 57:622–635. http://dx.doi.org/10.1016/j.molcel.2014.12.024.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Kibe T, Kabir S, de Lange T. 2014. TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1/POT1 repressor of ATR signaling. Genes Dev 28:2477–2491. http://dx.doi.org/10.1101/gad.251611.114.
   PubMed Web of Science ®Google Scholar
• Kim MK, Smith S. 2014. Persistent telomere cohesion triggers a prolonged anaphase. Mol Biol Cell 25:30–40. http://dx.doi.org/10.1091/mbc.E13-08-0479.
   PubMedGoogle Scholar
• Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, Roth MG, Amatruda JF, Chen C, Lum L. 2009. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5:100–107. http://dx.doi.org/10.1038/nchembio.137.
   PubMed Web of Science ®Google Scholar
• Lehtio L, Collins R, van den Berg S, Johansson A, Dahlgren LG, Hammarstrom M, Helleday T, Holmberg-Schiavone L, Karlberg T, Weigelt J. 2008. Zinc binding catalytic domain of human tankyrase 1. J Mol Biol 379:136–145. http://dx.doi.org/10.1016/j.jmb.2008.03.058.
   PubMed Web of Science ®Google Scholar
• McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr 40:658–674. http://dx.doi.org/10.1107/S0021889807021206.
   PubMed Web of Science ®Google Scholar
• Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, Moriarty NW, Read RJ, Sacchettini JC, Sauter NK, Terwilliger TC. 2002. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D 58:1948–1954. http://dx.doi.org/10.1107/S0907444902016657.
   PubMed Web of Science ®Google Scholar
• Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr D 60:2126–2132. http://dx.doi.org/10.1107/S0907444904019158.
   PubMed Web of Science ®Google Scholar
• Chen VB, Arendall WB, III, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D 66:12–21. http://dx.doi.org/10.1107/S0907444909042073.
   PubMed Web of Science ®Google Scholar
• Lum L, Reid MS, Blobel CP. 1998. Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J Biol Chem 273:26236–26247. http://dx.doi.org/10.1074/jbc.273.40.26236.
   PubMed Web of Science ®Google Scholar
• Ludlow AT, Robin JD, Sayed M, Litterst CM, Shelton DN, Shay JW, Wright WE. 2014. Quantitative telomerase enzyme activity determination using droplet digital PCR with single cell resolution. Nucleic Acids Res 42:e104. http://dx.doi.org/10.1093/nar/gku439.
   PubMedGoogle Scholar
• Huang H, He X. 2008. Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol 20:119–125. http://dx.doi.org/10.1016/j.ceb.2008.01.009.
   PubMed Web of Science ®Google Scholar
• Narwal M, Venkannagari H, Lehtio L. 2012. Structural basis of selective inhibition of human tankyrases. J Med Chem 55:1360–1367. http://dx.doi.org/10.1021/jm201510p.
   PubMed Web of Science ®Google Scholar
• Gunaydin H, Gu Y, Huang X. 2012. Novel binding mode of a potent and selective tankyrase inhibitor. PLoS One 7:e33740. http://dx.doi.org/10.1371/journal.pone.0033740.
   PubMedGoogle Scholar
• Wahlberg E, Karlberg T, Kouznetsova E, Markova N, Macchiarulo A, Thorsell AG, Pol E, Frostell A, Ekblad T, Oncu D, Kull B, Robertson GM, Pellicciari R, Schuler H, Weigelt J. 2012. Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat Biotechnol 30:283–288. http://dx.doi.org/10.1038/nbt.2121.
   PubMed Web of Science ®Google Scholar
• Palm W, de Lange T. 2008. How shelterin protects mammalian telomeres. Annu Rev Genet 42:301–334. http://dx.doi.org/10.1146/annurev.genet.41.110306.130350.
   PubMed Web of Science ®Google Scholar
• Shay JW, Wright WE. 2011. Role of telomeres and telomerase in cancer. Semin Cancer Biol 21:349–353. http://dx.doi.org/10.1016/j.semcancer.2011.10.001.
   PubMed Web of Science ®Google Scholar
• Takai H, Smogorzewska A, de Lange T. 2003. DNA damage foci at dysfunctional telomeres. Curr Biol 13:1549–1556. http://dx.doi.org/10.1016/S0960-9822(03)00542-6.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Sancho JM, Brennan KR, Castelo-Soccio LA, Brown AM. 2004. Wnt proteins induce dishevelled phosphorylation via an LRP5/6-independent mechanism, irrespective of their ability to stabilize beta-catenin. Mol Cell Biol 24:4757–4768. http://dx.doi.org/10.1128/MCB.24.11.4757-4768.2004.
   PubMedGoogle Scholar
• Jacob LS, Wu X, Dodge ME, Fan CW, Kulak O, Chen B, Tang W, Wang B, Amatruda JF, Lum L. 2011. Genome-wide RNAi screen reveals disease-associated genes that are common to Hedgehog and Wnt signaling. Sci Signal 4:ra4. http://dx.doi.org/10.1126/scisignal.2001225.
   PubMedGoogle Scholar
• Chang W, Dynek JN, Smith S. 2003. TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev 17:1328–1333. http://dx.doi.org/10.1101/gad.1077103.
   PubMed Web of Science ®Google Scholar
• Seimiya H, Muramatsu Y, Ohishi T, Tsuruo T. 2005. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Cancer Cell 7:25–37. http://dx.doi.org/10.1016/j.ccr.2004.11.021.
   PubMed Web of Science ®Google Scholar
• Tian X, Hou W, Bai S, Fan J, Tong H, Bai Y. 2014. XAV939 promotes apoptosis in a neuroblastoma cell line via telomere shortening. Oncol Rep 32:1999–2006. http://dx.doi.org/10.3892/or.2014.3460.
   PubMedGoogle Scholar
• Lum L, Clevers H. 2012. Cell biology. The unusual case of Porcupine. Science 337:922–923. http://dx.doi.org/10.1126/science.1228179.
   PubMedGoogle Scholar
• Diala I, Wagner N, Magdinier F, Shkreli M, Sirakov M, Bauwens S, Schluth-Bolard C, Simonet T, Renault VM, Ye J, Djerbi A, Pineau P, Choi J, Artandi S, Dejean A, Plateroti M, Gilson E. 2013. Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway. EMBO Rep 14:356–363. http://dx.doi.org/10.1038/embor.2013.16.
   PubMed Web of Science ®Google Scholar
• Hoffmeyer K, Raggioli A, Rudloff S, Anton R, Hierholzer A, Del Valle I, Hein K, Vogt R, Kemler R. 2012. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science 336:1549–1554. http://dx.doi.org/10.1126/science.1218370.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Toh L, Lau P, Wang X. 2012. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/beta-catenin pathway in human cancer. J Biol Chem 287:32494–32511. http://dx.doi.org/10.1074/jbc.M112.368282.
   PubMed Web of Science ®Google Scholar
• Ghaedi M, Calle EA, Mendez JJ, Gard AL, Balestrini J, Booth A, Bove PF, Gui L, White ES, Niklason LE. 2013. Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix. J Clin Invest 123:4950–4962. http://dx.doi.org/10.1172/JCI68793.
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Lee JW, Schultz PG. 2011. Stepwise chemically induced cardiomyocyte specification of human embryonic stem cells. Angew Chem Int Ed Engl 50:11181–11185. http://dx.doi.org/10.1002/anie.201103909.
   PubMedGoogle Scholar
• Huang SX, Islam MN, O'Neill J, Hu Z, Yang YG, Chen YW, Mumau M, Green MD, Vunjak-Novakovic G, Bhattacharya J, Snoeck HW. 2014. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol 32:84–91. http://dx.doi.org/10.1038/nbt.2754.
   PubMed Web of Science ®Google Scholar
• Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, Hsiao C, Kamp TJ, Palecek SP. 2013. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat Protoc 8:162–175. http://dx.doi.org/10.1038/nprot.2012.150.
   PubMed Web of Science ®Google Scholar
• Nakano T, Ando S, Takata N, Kawada M, Muguruma K, Sekiguchi K, Saito K, Yonemura S, Eiraku M, Sasai Y. 2012. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 10:771–785. http://dx.doi.org/10.1016/j.stem.2012.05.009.
   PubMed Web of Science ®Google Scholar
• Narytnyk A, Verdon B, Loughney A, Sweeney M, Clewes O, Taggart MJ, Sieber-Blum M. 2014. Differentiation of human epidermal neural crest stem cells (hEPI-NCSC) into virtually homogenous populations of dopaminergic neurons. Stem Cell Rev 10:316–326. http://dx.doi.org/10.1007/s12015-013-9493-9.
   Google Scholar
• Ren Y, Lee MY, Schliffke S, Paavola J, Amos PJ, Ge X, Ye M, Zhu S, Senyei G, Lum L, Ehrlich BE, Qyang Y. 2011. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. J Mol Cell Cardiol 51:280–287. http://dx.doi.org/10.1016/j.yjmcc.2011.04.012.
   PubMed Web of Science ®Google Scholar
• Wang H, Hao J, Hong CC. 2011. Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/beta-catenin signaling. ACS chemical biology 6:192–197. http://dx.doi.org/10.1021/cb100323z.
   PubMedGoogle Scholar
• Williams SCP. 2013. No end in sight for telomerase-targeted cancer drugs. Nat Med 19:6. http://dx.doi.org/10.1038/nm0113-6.
   PubMedGoogle Scholar
• Thompson PA, Drissi R, Muscal JA, Panditharatna E, Fouladi M, Ingle AM, Ahern CH, Reid JM, Lin T, Weigel BJ, Blaney SM. 2013. A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112). Clin Cancer Res 19:6578–6584. http://dx.doi.org/10.1158/1078-0432.CCR-13-1117.
   PubMed Web of Science ®Google Scholar
• Cerone MA, Burgess DJ, Naceur-Lombardelli C, Lord CJ, Ashworth A. 2011. High-throughput RNAi screening reveals novel regulators of telomerase. Cancer Res 71:3328–3340. http://dx.doi.org/10.1158/0008-5472.CAN-10-2734.
   PubMedGoogle Scholar
• Haikarainen T, Venkannagari H, Narwal M, Obaji E, Lee HW, Nkizinkiko Y, Lehtio L. 2013. Structural basis and selectivity of tankyrase inhibition by a Wnt signaling inhibitor WIKI4. PLoS One 8:e65404. http://dx.doi.org/10.1371/journal.pone.0065404.
   PubMedGoogle Scholar
• Ramsay AJ, Quesada V, Foronda M, Conde L, Martinez-Trillos A, Villamor N, Rodriguez D, Kwarciak A, Garabaya C, Gallardo M, Lopez-Guerra M, Lopez-Guillermo A, Puente XS, Blasco MA, Campo E, Lopez-Otin C. 2013. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet 45:526–530. http://dx.doi.org/10.1038/ng.2584.
   PubMed Web of Science ®Google Scholar
• Robles-Espinoza CD, Harland M, Ramsay AJ, Aoude LG, Quesada V, Ding Z, Pooley KA, Pritchard AL, Tiffen JC, Petljak M, Palmer JM, Symmons J, Johansson P, Stark MS, Gartside MG, Snowden H, Montgomery GW, Martin NG, Liu JZ, Choi J, Makowski M, Brown KM, Dunning AM, Keane TM, Lopez-Otin C, Gruis NA, Hayward NK, Bishop DT, Newton-Bishop JA, Adams DJ. 2014. POT1 loss-of-function variants predispose to familial melanoma. Nat Genet 46:478–481. http://dx.doi.org/10.1038/ng.2947.
   PubMed Web of Science ®Google Scholar
• Shi J, Yang XR, Ballew B, Rotunno M, Calista D, Fargnoli MC, Ghiorzo P, Bressac-de Paillerets B, Nagore E, Avril MF, Caporaso NE, McMaster ML, Cullen M, Wang Z, Zhang X, Bruno W, Pastorino L, Queirolo P, Banuls-Roca J, Garcia-Casado Z, Vaysse A, Mohamdi H, Riazalhosseini Y, Foglio M, Jouenne F, Hua X, Hyland PL, Yin J, Vallabhaneni H, Chai W, Minghetti P, Pellegrini C, Ravichandran S, Eggermont A, Lathrop M, Peris K, Scarra GB, Landi G, Savage SA, Sampson JN, He J, Yeager M, Goldin LR, Demenais F, Chanock SJ, Tucker MA, Goldstein AM, Liu Y, Landi MT. 2014. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet 46:482–486. http://dx.doi.org/10.1038/ng.2941.
   PubMed Web of Science ®Google Scholar
• Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R. 2013. TERT promoter mutations in familial and sporadic melanoma. Science 339:959–961. http://dx.doi.org/10.1126/science.1230062.
   PubMed Web of Science ®Google Scholar
• Borah S, Xi L, Zaug AJ, Powell NM, Dancik GM, Cohen SB, Costello JC, Theodorescu D, Cech TR. 2015. Cancer TERT promoter mutations and telomerase reactivation in urothelial cancer. Science 347:1006–1010. http://dx.doi.org/10.1126/science.1260200.
   PubMed Web of Science ®Google Scholar
• Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, Kollmeyer T, Kosel ML, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Pekmezci M, Zheng S, Wiemels JL, Pico AR, Tihan T, Berger MS, Chang SM, Prados MD, Lachance DH, O'Neill BP, Sicotte H, Eckel-Passow JE, van der Harst P, Wiencke JK, Samani NJ, Jenkins RB, Wrensch MR. 2014. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet 46:731–735. http://dx.doi.org/10.1038/ng.3004.
   PubMed Web of Science ®Google Scholar
• Scholer-Dahirel A, Schlabach MR, Loo A, Bagdasarian L, Meyer R, Guo R, Woolfenden S, Yu KK, Markovits J, Killary K, Sonkin D, Yao YM, Warmuth M, Sellers WR, Schlegel R, Stegmeier F, Mosher RE, McLaughlin ME. 2011. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 108:17135–17140. http://dx.doi.org/10.1073/pnas.1104182108.
   PubMed Web of Science ®Google Scholar
• Munoz P, Blanco R, de Carcer G, Schoeftner S, Benetti R, Flores JM, Malumbres M, Blasco MA. 2009. TRF1 controls telomere length and mitotic fidelity in epithelial homeostasis. Mol Cell Biol 29:1608–1625. http://dx.doi.org/10.1128/MCB.01339-08.
   PubMedGoogle Scholar
• Ohki R, Ishikawa F. 2004. Telomere-bound TRF1 and TRF2 stall the replication fork at telomeric repeats. Nucleic Acids Res 32:1627–1637. http://dx.doi.org/10.1093/nar/gkh309.
   PubMed Web of Science ®Google Scholar